Key takeaways
The Senate Appropriations Committee released its FY2027 Commerce, Justice, Science bill on Nov. 12, 2026.
Section 531 keeps the medical marijuana shield, naming 48 states plus D.C., Guam, Puerto Rico, the U.S. Virgin Islands and the Northern Mariana Islands.
The Senate bill leaves out the House’s ban on spending money to reschedule marijuana, which the House committee approved 32-28 in May.
Report language asks for briefings on CBP seizures from state-legal cannabis businesses and on illegal grows tied to foreign nationals. No committee vote is scheduled yet.
The Senate’s version of next year’s Justice Department funding bill keeps the federal shield for state medical marijuana programs. Unlike the House version, it doesn’t try to stop federal marijuana rescheduling.
The Senate Appropriations Committee released the text of five FY2027 funding bills on Nov. 12, including Commerce, Justice, Science (CJS) and Homeland Security. Marijuana Moment first reported the cannabis provisions and noted the panel hasn’t scheduled votes on any of the measures.
What the Senate medical marijuana rider says
Section 531 of the Senate CJS bill bars the Justice Department from using its funds to stop listed states and territories from carrying out their own medical marijuana laws. Versions of the rider have been federal law since 2014. This one names 48 states, every state but Idaho and Kansas, plus D.C., the Northern Mariana Islands, the U.S. Virgin Islands, Guam and Puerto Rico.
Nebraska is on the list. Marijuana Moment reported in May that advocates had pointed out the state was missing from earlier enacted versions even though voters approved medical cannabis in 2024. Section 530 also keeps the longstanding rider protecting state hemp research programs from DOJ and DEA interference.
How the Senate and House bills differ
Provision | House CJS bill (May) | Senate CJS bill (Nov. 12) |
|---|---|---|
Medical marijuana shield | Yes, including Nebraska | Yes, 48 states plus D.C. and 4 territories |
Ban on funds to reschedule marijuana | Yes | No |
DOJ can enforce school-zone law (21 U.S.C. 860) | Written into the rider | Report language only |
Committee vote | Approved 32-28 on May 13 | Not scheduled |
The House rider would block funds from being used to reschedule marijuana or remove it from the Controlled Substances Act schedules. That matters because the Justice Department moved state-licensed medical marijuana to Schedule III in April, and a DEA hearing is weighing broader rescheduling, per Marijuana Moment.
On school zones, the Senate CJS report leaves the point out of the bill and handles it in report language instead:
"The Committee appreciates the Department’s clarification that section 531 of this act does not explicitly preclude the USAOs from enforcing section 860 of title 21, United States Code."
Other cannabis language in the Senate reports
CBP seizures: the Homeland Security report asks Customs and Border Protection for a briefing within 120 days on seizures of cannabis products from distributors complying with state or tribal law.
Illegal grows: DOJ would report within 90 days on illegal marijuana grows tied to foreign nationals, including any links to Chinese transnational criminal organizations.
Kratom: DEA would brief Congress within 60 days on kratom’s health and safety impacts.
DEA budget: the committee recommends $2.7036 billion for DEA salaries and expenses, $123.26 million above FY2026, plus $676.4 million from the diversion control fee account.
What this means for operators
Watch the conference fight. The House and Senate have to settle the rescheduling ban, and that outcome could affect how fast Schedule III moves beyond medical.
Don’t read the rider as broad protection. It covers DOJ funds and state medical programs, not adult-use sales or other agencies.
Document any CBP seizures of compliant product. The requested briefing shows Congress is paying attention.
Mark Dec. 11. It’s the next federal funding deadline, DPS Law notes, so a stopgap could carry the current rider forward.
What this means for cannabis workers
For people working in medical programs, the shield is the federal backstop that keeps DOJ from using its money to block state programs. The Senate bill would keep it in place for another year if it becomes law.
Nothing changes on the job yet. These are committee drafts, and neither chamber has passed a final FY2027 CJS bill.
The bigger picture
The two chambers now agree on keeping the medical shield and disagree on rescheduling. The House committee’s bill next heads to the Rules Committee before the floor, Marijuana Moment reported in May. Whatever version wins will shape federal cannabis policy for fiscal 2027.
Related on The Weekly Joint: DEA show-cause orders hit medical cannabis states · DEA keeps 2027 marijuana quotas flat · Archive
Sources
This article is general information, not legal advice.
Get the week in cannabis business, every Tuesday
The Weekly Joint covers regulation, licensing, money and the cannabis workforce, with every story linked to its source. Free, once a week.
Prefer the scroll? Follow @weeklyjoint on Instagram.
